Trial Profile
Immunogenicity and Safety of a Herpes Zoster Vaccine (Zostavax) in Patients With Systemic Lupus Erythematosus: a Randomized Controlled Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Varicella zoster virus vaccine live (Primary)
- Indications Varicella zoster virus infections
- Focus Pharmacodynamics
- 17 Sep 2019 Results published in the Annals of the Rheumatic Diseases
- 02 Sep 2019 Status changed from active, no longer recruiting to completed.
- 24 Oct 2018 Results presented at the 82nd American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting